Company News in the Life Science Industry

»

Reset 

Health Canada certifies Winnipeg Ventilator 2.0 for immediate distribution to support the needs of Covid-19 patients

VICTORIA, BC, Sept. 25, 2020 /PRNewswire/ - StarFish Medical, Canada's largest medical device design, development, and manufacturing service provider, announced today that the Winnipeg Ventilator 2.0 has received a Health Canada COVID-19 Medical Device Authorization under the Interim Order Respecting... Read more ››

By: PR Newswire Association LLC. - 25 Sep 2020
Related companies:  StarFish Medical | StarFish Medical

ImmunoPrecise and LiteVax SARS-CoV-2 Vaccine Begins Pre-Clinical Trials

VICTORIA, BC, Sept. 25, 2020 /PRNewswire/ - IMMUNOPRECISE ANTIBODIES LTD. ("IPA") (TSXV: IPA) (OTCQB: IPATF) (FSE: TQB2), a leader in full-service, therapeutic antibody discovery and development, and LiteVax BV (Oss, the Netherlands), today announced that they have initiated pre-clinical vaccine... Read more ››

By: PR Newswire Association LLC. - 25 Sep 2020
Related companies:  ImmunoPrecise Antibodies Ltd.

FDA Approves Bausch + Lomb Alaway® Preservative Free (Ketotifen Fumarate) Ophthalmic Solution, 0.035%

LAVAL, QC and DEER PARK, Ill., Sept. 25, 2020 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), Bausch + Lomb, a leading global eye health business, and Eton Pharmaceuticals, Inc. (NASDAQ: ETON) today announced that the U.S. Food and Drug Administration (FDA) has... Read more ››

By: PR Newswire Association LLC. - 25 Sep 2020
Related companies:  Bausch Health Companies Inc.

Ruzurgi® Now Available to Canadian Lambert-Eaton Myasthenic Syndrome (LEMS) Patients

BLAINVILLE, QC, Sept. 25, 2020 /CNW Telbec/ - Médunik Canada, a pharmaceutical company dedicated to improving the health and quality of life of Canadians with rare diseases, is extremely pleased to announce that its new orphan disease product Ruzurgi(®) (amifampridine) is now commercially available... Read more ››

By: PR Newswire Association LLC. - 25 Sep 2020
Related companies:  Medunik Canada

Searchlight Pharma named to The Globe and Mail's second-annual ranking of Canada's Top Growing Companies

MONTREAL, Sept. 25, 2020 /CNW Telbec/ - Searchlight Pharma is pleased to announce that it has been named to The Globe and Mail's Report on Business second-annual ranking of Canada's Top Growing Companies. Based on a three-year growth rate of 260% (2016-2019), Searchlight Pharma ranked No. 172... Read more ››

By: PR Newswire Association LLC. - 25 Sep 2020
Related companies:  Searchlight Pharma Inc.

Rx Drug Mart Named Fastest Growing Company in Canada by The Globe and Mail

Leading operator of independent pharmacies celebrates 3-year revenue growth of 13,940%

Read more ››
By: PR Newswire Association LLC. - 25 Sep 2020

Health Canada Approves Portable Human COVID-19 Testing Device that Delivers Results in 90 Minutes

GUELPH, ON, Sept. 25, 2020 /CNW/ - Health Canada has granted approval for the Hyris bCUBE to be used as a Read more ››

By: PR Newswire Association LLC. - 25 Sep 2020

Medical technology innovation company, Thornhill Medical, ranked as one of The Globe and Mail's Canada's Top Growing Companies

TORONTO, Sept. 25, 2020 /CNW/ - Canada's medical technology innovator Thornhill Medical is pleased to announce it has placed #62 on the Read more ››

By: PR Newswire Association LLC. - 25 Sep 2020

Recognizing the scientific impact of Dr. Frank Graham's HEK 293 cell line

OTTAWA,ON, Sept. 25, 2020 /CNW/ - The National Research Council of Canada (NRC) today formally recognized the scientific impact of the HEK 293 cell line, originally created by Dr. Frank Graham nearly 50 years ago, and its importance in the production of biologic molecules, including current COVID-19... Read more ››

By: PR Newswire Association LLC. - 25 Sep 2020

Laboratory staffing approach key to Ontario's response to COVID-19 pandemic

HAMILTON, ON, Sept. 25, 2020 /CNW/ - The Canadian Society for Medical Laboratory Science (CSMLS) congratulates the Government of Ontario for its $1.07 billion investment in expanding COVID-19 testing and case and contact management. However, there is concern regarding the approach to staffing... Read more ››

By: PR Newswire Association LLC. - 25 Sep 2020
Related companies:  Canadian Society for Medical Laboratory Science (CSMLS)

Availability of the Q3 2020 Memorandum for modelling purposes

Read more ››
By: GlobenewsWire - 25 Sep 2020

Tiziana Life Sciences Interview to Air on Bloomberg International on The RedChip Money Report

Read more ››
By: GlobenewsWire - 25 Sep 2020
Related companies:  Tiziana Life Sciences plc

BioPorto A/S publishes prospectus in connection with a fully-guaranteed rights issue with pre-emptive subscription rights for its existing shareholders

Read more ››
By: GlobenewsWire - 25 Sep 2020
Related companies:  BioPorto Diagnostics A/S

Jyseleca® (filgotinib) approved in Japan for rheumatoid arthritis

Read more ››
By: GlobenewsWire - 25 Sep 2020
Related companies:  Galapagos NV

Pilot Study for New Chronic Pain Treatment Protocol with Nexstim NBT® System Starts in Helsinki University Hospital

Read more ››
By: GlobenewsWire - 25 Sep 2020

Orphazyme A/S provides update on previously announced global offering

Read more ››
By: GlobenewsWire - 25 Sep 2020
Related companies:  Orphazyme A/S

Opthea Files Registration Statement for Proposed Initial Public Offering in the United States

Read more ››
By: GlobenewsWire - 25 Sep 2020
Related companies:  Opthea Limited

Aesthetic Medical International Holdings Group Limited Reports Second Quarter 2020 Unaudited Financial Results

Read more ››
By: GlobenewsWire - 25 Sep 2020

CStone Announces Preliminary Results from a Bridging Study of Avapritinib in Chinese Patients with Unresectable or Metastatic Gastrointestinal Stromal Tumors at the 2020 CSCO Annual Meeting

SUZHOU, China, Sept. 25, 2020 /PRNewswire/ -- CStone Pharmaceuticals (SUZHOU) Co., Ltd. ("CStone", HKEX: 2616) presented positive results at the 2020 Chinese Society of Clinical Oncology (CSCO) Annual Meeting from a phase I/II bridging study in China evaluating avapritinib in patients with unresectable... Read more ››

By: PR Newswire Association LLC. - 25 Sep 2020
Related companies:  CStone Pharmaceuticals

RDIF and LAXISAM agree to supply up to 35 million doses of Sputnik V vaccine to Uzbekistan

MOSCOW, Sept. 25, 2020 /PRNewswire/ -- The Russian Direct Investment Fund (RDIF), Russia's sovereign wealth fund, and LAXISAM, one of the leading pharmaceutical companies in the Republic of Uzbekistan, have agreed to supply to the country up to 35 million doses of the Sputnik V vaccine, which... Read more ››

By: PR Newswire Association LLC. - 25 Sep 2020
«  1  2  3  4 5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies